Tonix Pharmaceuticals announced that the FDA cleared an IND application for a Phase 1 clinical trial of TNX-1500 for the prevention of organ rejection in kidney transplant patients.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.